Skip to content
Disclosery

Holocene Advisors, LP: CNC position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Holocene Advisors, LP on CNC, newest first. How the timeline and the estimate are built.

Holocene Advisors, LP held 0 CNC shares at 2026-03-31 per its 13F-HR filed 2026-05-15.

the latest 13F is the newest step

  1. period ended2026-03-31
    13F 0 shares
    Change vs previous 13F -2,359,513 shares

    13F-HR 0001172661-26-002328 filed by Holocene Advisors, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-12-31
    13F 2,359,513 shares
    Change vs previous 13F +2,359,513 shares

    0.2% of the 13F portfolio, value $97,093,960.

    13F-HR 0001172661-26-001069 filed by Holocene Advisors, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-06-30
    13F 0 shares
    Change vs previous 13F -1,210,949 shares

    13F-HR 0001172661-25-003485 filed by Holocene Advisors, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  4. period ended2025-03-31
    13F 1,210,949 shares
    Change vs previous 13F +37,401 shares

    0.22% of the 13F portfolio, value $73,516,714.

    13F-HR 0001172661-25-002386 filed by Holocene Advisors, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-12-31
    13F 1,173,548 shares
    Change vs previous 13F not available

    0.23% of the 13F portfolio, value $71,093,538.

    13F-HR 0001172661-25-001140 filed by Holocene Advisors, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).